Repligen Corporation (RGEN)
USD 108.89
(-6.22%)
USD 108.89
(-6.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 41.57 Million USD | -77.64% |
| 2022 | 185.95 Million USD | 44.95% |
| 2021 | 128.29 Million USD | 114.08% |
| 2020 | 59.92 Million USD | 179.88% |
| 2019 | 21.41 Million USD | 28.85% |
| 2018 | 16.61 Million USD | -41.39% |
| 2017 | 28.35 Million USD | 142.73% |
| 2016 | 11.68 Million USD | 25.0% |
| 2015 | 9.34 Million USD | 14.38% |
| 2014 | 8.17 Million USD | -49.23% |
| 2013 | 16.09 Million USD | 13.68% |
| 2012 | 14.15 Million USD | 32635.88% |
| 2011 | -43.5 Thousand USD | 98.93% |
| 2010 | -4.06 Million USD | -170.72% |
| 2009 | 5.74 Million USD | -84.51% |
| 2008 | 37.1 Million USD | 4272.73% |
| 2007 | -889.26 Thousand USD | -227.61% |
| 2006 | 696.86 Thousand USD | 123.36% |
| 2005 | -2.98 Million USD | 68.76% |
| 2004 | -9.55 Million USD | -110.51% |
| 2003 | -4.53 Million USD | -1.71% |
| 2002 | -4.46 Million USD | 15.5% |
| 2001 | -5.27 Million USD | -38.32% |
| 2000 | -3.81 Million USD | -52.66% |
| 1999 | -2.5 Million USD | -212.5% |
| 1998 | -800 Thousand USD | -60.0% |
| 1997 | -500 Thousand USD | 95.65% |
| 1996 | -11.5 Million USD | 64.06% |
| 1995 | -32 Million USD | -64.1% |
| 1994 | -19.5 Million USD | -72.57% |
| 1993 | -11.3 Million USD | 11.72% |
| 1992 | -12.8 Million USD | -124.56% |
| 1991 | -5.7 Million USD | -137.5% |
| 1990 | -2.4 Million USD | 27.27% |
| 1989 | -3.3 Million USD | -1200.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 3.32 Million USD | 58.6% |
| 2024 Q1 | 2.09 Million USD | 108.22% |
| 2023 FY | 41.57 Million USD | -77.64% |
| 2023 Q2 | 20.06 Million USD | -30.4% |
| 2023 Q4 | -25.48 Million USD | -240.26% |
| 2023 Q3 | 18.17 Million USD | -9.43% |
| 2023 Q1 | 28.82 Million USD | -40.84% |
| 2022 Q4 | 48.72 Million USD | 20.6% |
| 2022 FY | 185.95 Million USD | 44.95% |
| 2022 Q2 | 49.86 Million USD | 6.17% |
| 2022 Q1 | 46.96 Million USD | 61.33% |
| 2022 Q3 | 40.4 Million USD | -18.96% |
| 2021 Q1 | 29.45 Million USD | 49.51% |
| 2021 Q4 | 29.11 Million USD | -13.1% |
| 2021 Q3 | 33.49 Million USD | -7.55% |
| 2021 Q2 | 36.23 Million USD | 23.03% |
| 2021 FY | 128.29 Million USD | 114.08% |
| 2020 Q1 | 9.81 Million USD | 172.34% |
| 2020 Q4 | 19.69 Million USD | 35.36% |
| 2020 Q3 | 14.55 Million USD | -8.25% |
| 2020 FY | 59.92 Million USD | 179.88% |
| 2020 Q2 | 15.86 Million USD | 61.6% |
| 2019 Q2 | 8.09 Million USD | 0.52% |
| 2019 FY | 21.41 Million USD | 28.85% |
| 2019 Q1 | 8.05 Million USD | 42.83% |
| 2019 Q4 | 3.6 Million USD | 117.24% |
| 2019 Q3 | 1.65 Million USD | -79.51% |
| 2018 Q4 | 5.63 Million USD | 17.61% |
| 2018 FY | 16.61 Million USD | -41.39% |
| 2018 Q1 | 3.44 Million USD | -71.69% |
| 2018 Q2 | 2.73 Million USD | -20.59% |
| 2018 Q3 | 4.79 Million USD | 75.09% |
| 2017 Q1 | 3.06 Million USD | -38.99% |
| 2017 Q2 | 8.43 Million USD | 175.03% |
| 2017 Q3 | 4.66 Million USD | -44.67% |
| 2017 Q4 | 12.17 Million USD | 160.83% |
| 2017 FY | 28.35 Million USD | 142.73% |
| 2016 FY | 11.68 Million USD | 25.0% |
| 2016 Q1 | 1.62 Million USD | 513.21% |
| 2016 Q2 | 3.87 Million USD | 138.28% |
| 2016 Q3 | 1.15 Million USD | -70.17% |
| 2016 Q4 | 5.02 Million USD | 335.41% |
| 2015 Q3 | 2.53 Million USD | -29.75% |
| 2015 Q2 | 3.61 Million USD | 23.32% |
| 2015 Q4 | 265 Thousand USD | -89.56% |
| 2015 Q1 | 2.92 Million USD | 835.05% |
| 2015 FY | 9.34 Million USD | 14.38% |
| 2014 Q3 | 1.46 Million USD | -48.11% |
| 2014 Q1 | 4.27 Million USD | 28.54% |
| 2014 Q2 | 2.82 Million USD | -33.94% |
| 2014 Q4 | -398.54 Thousand USD | -127.18% |
| 2014 FY | 8.17 Million USD | -49.23% |
| 2013 Q2 | 4.53 Million USD | 94.13% |
| 2013 Q4 | 3.32 Million USD | -43.49% |
| 2013 Q1 | 2.33 Million USD | -75.52% |
| 2013 FY | 16.09 Million USD | 13.68% |
| 2013 Q3 | 5.88 Million USD | 29.72% |
| 2012 Q3 | 1.8 Million USD | 15.07% |
| 2012 Q4 | 9.55 Million USD | 428.82% |
| 2012 Q1 | 1.22 Million USD | 0.0% |
| 2012 Q2 | 1.56 Million USD | 28.01% |
| 2012 FY | 14.15 Million USD | 32635.88% |
| 2011 FY | -43.5 Thousand USD | 98.93% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | -55.59 Thousand USD | 97.26% |
| 2011 Q1 | -2.03 Million USD | -640.2% |
| 2011 Q3 | 604.67 Thousand USD | 1187.6% |
| 2010 Q3 | 623.2 Thousand USD | -36.93% |
| 2010 FY | -4.06 Million USD | -170.72% |
| 2010 Q4 | 375.91 Thousand USD | -39.68% |
| 2010 Q1 | -1.62 Million USD | -366.91% |
| 2010 Q2 | 988.05 Thousand USD | 160.65% |
| 2009 Q3 | -979.7 Thousand USD | 11.42% |
| 2009 Q1 | -2.69 Million USD | -14751.5% |
| 2009 FY | 5.74 Million USD | -84.51% |
| 2009 Q2 | -1.1 Million USD | 58.93% |
| 2009 Q4 | -348.93 Thousand USD | 64.38% |
| 2008 Q2 | 8.27 Million USD | 358.91% |
| 2008 FY | 37.1 Million USD | 4272.73% |
| 2008 Q1 | -3.19 Million USD | -1221.69% |
| 2008 Q3 | 142.05 Thousand USD | -98.28% |
| 2008 Q4 | 18.38 Thousand USD | -87.06% |
| 2007 FY | -889.26 Thousand USD | -227.61% |
| 2007 Q3 | 40.3 Million USD | 16695.74% |
| 2007 Q2 | 239.97 Thousand USD | 324.34% |
| 2007 Q4 | -241.93 Thousand USD | -100.6% |
| 2007 Q1 | -106.96 Thousand USD | -442.74% |
| 2006 Q4 | -19.7 Thousand USD | 97.72% |
| 2006 FY | 696.86 Thousand USD | 123.36% |
| 2006 Q1 | -819.64 Thousand USD | -305.14% |
| 2006 Q2 | 100.73 Thousand USD | 112.29% |
| 2006 Q3 | -863.31 Thousand USD | -957.03% |
| 2005 FY | -2.98 Million USD | 68.76% |
| 2005 Q4 | -202.31 Thousand USD | 56.73% |
| 2005 Q3 | -467.5 Thousand USD | -121.38% |
| 2005 Q2 | 2.18 Million USD | 612.46% |
| 2005 Q1 | -426.63 Thousand USD | -120.79% |
| 2004 Q2 | -645.08 Thousand USD | 80.19% |
| 2004 Q1 | -3.25 Million USD | -53.08% |
| 2004 Q3 | -1.71 Million USD | -166.42% |
| 2004 Q4 | -193.22 Thousand USD | 88.76% |
| 2004 FY | -9.55 Million USD | -110.51% |
| 2003 Q2 | -2.02 Million USD | -19.47% |
| 2003 FY | -4.53 Million USD | -1.71% |
| 2003 Q4 | -2.12 Million USD | 0.62% |
| 2003 Q3 | -2.14 Million USD | -5.54% |
| 2003 Q1 | -1.69 Million USD | -121.64% |
| 2002 Q4 | -765.85 Thousand USD | 29.26% |
| 2002 FY | -4.46 Million USD | 15.5% |
| 2002 Q1 | -922.91 Thousand USD | -12.92% |
| 2002 Q2 | -991.13 Thousand USD | -7.39% |
| 2002 Q3 | -1.08 Million USD | -9.23% |
| 2001 Q4 | -817.31 Thousand USD | 40.64% |
| 2001 Q3 | -1.37 Million USD | -2.48% |
| 2001 Q2 | -1.34 Million USD | 11.22% |
| 2001 Q1 | -1.51 Million USD | 4.38% |
| 2001 FY | -5.27 Million USD | -38.32% |
| 2000 Q3 | -1.21 Million USD | -24.83% |
| 2000 Q2 | -970.94 Thousand USD | -18.93% |
| 2000 FY | -3.81 Million USD | -52.66% |
| 2000 Q1 | -816.38 Thousand USD | 51.98% |
| 2000 Q4 | -1.58 Million USD | -30.58% |
| 1999 Q2 | -400 Thousand USD | 75.0% |
| 1999 FY | -2.5 Million USD | -212.5% |
| 1999 Q1 | -1.6 Million USD | -433.33% |
| 1999 Q4 | -1.7 Million USD | -112.5% |
| 1999 Q3 | -800 Thousand USD | -100.0% |
| 1998 Q2 | -300 Thousand USD | 0.0% |
| 1998 Q1 | -300 Thousand USD | -200.0% |
| 1998 Q3 | -200 Thousand USD | 33.33% |
| 1998 FY | -800 Thousand USD | -60.0% |
| 1998 Q4 | -300 Thousand USD | -50.0% |
| 1997 Q4 | -100 Thousand USD | 50.0% |
| 1997 Q3 | -200 Thousand USD | -100.0% |
| 1997 Q2 | -100 Thousand USD | 50.0% |
| 1997 Q1 | -200 Thousand USD | -100.0% |
| 1997 FY | -500 Thousand USD | 95.65% |
| 1996 FY | -11.5 Million USD | 64.06% |
| 1996 Q4 | -100 Thousand USD | -133.33% |
| 1996 Q3 | 300 Thousand USD | 160.0% |
| 1996 Q2 | -500 Thousand USD | 91.07% |
| 1996 Q1 | -5.6 Million USD | -143.48% |
| 1995 Q1 | -13.3 Million USD | -129.31% |
| 1995 FY | -32 Million USD | -64.1% |
| 1995 Q4 | -2.3 Million USD | -155.56% |
| 1995 Q3 | -900 Thousand USD | 65.38% |
| 1995 Q2 | -2.6 Million USD | 80.45% |
| 1994 FY | -19.5 Million USD | -72.57% |
| 1994 Q4 | -5.8 Million USD | 15.94% |
| 1994 Q2 | -6 Million USD | -27.66% |
| 1994 Q1 | -4.7 Million USD | 14.55% |
| 1994 Q3 | -6.9 Million USD | -15.0% |
| 1993 Q3 | -4.7 Million USD | -2.17% |
| 1993 Q4 | -5.5 Million USD | -17.02% |
| 1993 Q2 | -4.6 Million USD | -35.29% |
| 1993 Q1 | -3.4 Million USD | 19.05% |
| 1993 FY | -11.3 Million USD | 11.72% |
| 1992 Q3 | -4.1 Million USD | -1125.0% |
| 1992 Q4 | -4.2 Million USD | -2.44% |
| 1992 FY | -12.8 Million USD | -124.56% |
| 1992 Q1 | -900 Thousand USD | 89.29% |
| 1992 Q2 | 400 Thousand USD | 144.44% |
| 1991 Q2 | -1.4 Million USD | 6.67% |
| 1991 Q1 | -1.5 Million USD | 6.25% |
| 1991 FY | -5.7 Million USD | -137.5% |
| 1991 Q3 | -2.2 Million USD | -57.14% |
| 1991 Q4 | -8.4 Million USD | -281.82% |
| 1990 Q2 | -1.3 Million USD | 0.0% |
| 1990 Q4 | -1.6 Million USD | -14.29% |
| 1990 FY | -2.4 Million USD | 27.27% |
| 1990 Q3 | -1.4 Million USD | -7.69% |
| 1990 Q1 | - USD | 0.0% |
| 1989 FY | -3.3 Million USD | -1200.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 165.659% |
| AngioDynamics, Inc. | -184.34 Million USD | 122.553% |
| AtriCure, Inc. | -30.43 Million USD | 236.596% |
| Avinger, Inc. | -18.32 Million USD | 326.949% |
| Azenta, Inc. | -14.25 Million USD | 391.625% |
| BioLife Solutions, Inc. | -66.42 Million USD | 162.591% |
| The Cooper Companies, Inc. | 294.2 Million USD | 85.868% |
| Daxor Corporation | 280.64 Thousand USD | -14715.066% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 373.569% |
| Femasys Inc. | -14.24 Million USD | 391.827% |
| GlucoTrack, Inc. | -7.09 Million USD | 685.839% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 1317.482% |
| Hologic, Inc. | 789.5 Million USD | 94.734% |
| ICU Medical, Inc. | -29.65 Million USD | 240.202% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 97.688% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 402.575% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | -38.107% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 723.958% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 723.958% |
| Masimo Corporation | 81.5 Million USD | 48.985% |
| Microbot Medical Inc. | -10.74 Million USD | 487.123% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -257.639% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 55.962% |
| Nephros, Inc. | -1.57 Million USD | 2739.81% |
| NovoCure Limited | -207.04 Million USD | 120.081% |
| NEXGEL, Inc. | -3.15 Million USD | 1416.978% |
| NEXGEL, Inc. | -3.15 Million USD | 1416.978% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 143.848% |
| OraSure Technologies, Inc. | 53.65 Million USD | 22.51% |
| Pro-Dex, Inc. | 2.12 Million USD | -1854.725% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 198.5% |
| Predictive Oncology Inc. | -13.98 Million USD | 397.319% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 1508.732% |
| QuidelOrtho Corporation | -10.1 Million USD | 511.653% |
| Sanara MedTech Inc. | -4.3 Million USD | 1066.189% |
| STAAR Surgical Company | 21.34 Million USD | -94.767% |
| Sharps Technology, Inc. | -9.84 Million USD | 522.46% |
| Utah Medical Products, Inc. | 16.63 Million USD | -149.937% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 131.498% |
| Jin Medical International Ltd. | 2.87 Million USD | -1344.534% |